For the Inventor, By the Inventor

Enter assignee name

Irvine, CA, United States of America

Sicor Inc.

USPTO Granted Patents = 26

% Expired Patents = 30.8

EPO Patents = 10

Trademarks = 4

Forward Citations = 28

Loading Chart...

Loading Chart...

35 inventors (with patents filed for the assignee):

Nicola Diulgheroff (14 out of 14 patents)

Alessandro Pontiroli (14 out of 24 patents)

Judith Aronhime (9 out of 89 patents)

4. Jonathan Busolli (8 out of 8 patents)

5. Marco Villa (8 out of 35 patents)

6. Moran Pirkes (7 out of 7 patents)

7. Alexandr Jegorov (6 out of 28 patents)

8. Francesca Scarpitta (6 out of 8 patents)

9. Peter Lindsay MacDonald (5 out of 7 patents)

10. Csilla Nemethne Racz (4 out of 5 patents)

11. Pierluigi Rossetto (4 out of 6 patents)

12. Adrienne Kovacsne-Mezei (3 out of 15 patents)

13. Ales Gavenda (3 out of 10 patents)

14. Roberta Volonte (3 out of 3 patents)

15. Ettore Bigatti (3 out of 3 patents)

Core Competencies:

Pemetrexed Diacid

Tiotropium Bromide

Lyophilization

Pharmaceutical Salts

Polymorphs

Imatinib Mesylate

Rocuronium Bromide

Oxaliplatin

Fludarabine Phosphate

19-Norsteroids

Palonosetron

Aqueous Compositions

26 patents: Sort by Forward Citations

1. 9718829 - Crystalline forms of pemetrexed diacid and processes for the preparation thereof (2017-08-01),

2. 9562050 - Crystalline forms of pemetrexed diacid and processes for the preparation thereof (2017-02-07),

3. 9156841 - Crystalline forms of pemetrexed diacid and processes for the preparation thereof (2015-10-13),

4. 9108962 - Forms of tiotropium bromide and processes for preparation thereof (2015-08-18),

5. 8846926 - Forms of tiotropium bromide and processes for preparation thereof (2014-09-30),

6. 8629152 - Processes for the preparation of lyophilized pharmaceutically acceptable salts of pemetrexed diacid (2014-01-14),

7. 8378103 - Process for the preparation of tiotropium bromide (2013-02-19),

8. 8362245 - Processes for preparing intermediates of pemetrexed (2013-01-29),

9. 8344143 - Process for the preparation of tiotropium bromide (2013-01-01),

10. 8217061 - Polymorphs of sorafenib tosylate and sorafenib hemi-tosylate, and processes for preparation thereof (2012-07-10),

11. 8163913 - Forms of tiotropium bromide and processes for preparation thereof (2012-04-24),

12. 8088919 - Crystalline forms of pemetrexed diacid and processes for the preparation thereof (2012-01-03),

13. 8067421 - Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form α (2011-11-29),

14. 7994180 - Processes for preparing intermediates of pemetrexed (2011-08-09),

15. 7977348 - Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form α (2011-07-12),

Sicor Inc., based in Irvine, California, specializes in the development and manufacturing of high-quality pharmaceutical products, particularly in the field of injectable medications. The company focuses on advanced drug delivery systems and is recognized for its commitment to innovation in the biopharmaceutical sector. With a strong emphasis on research and development, Sicor aims to enhance patient care through effective and reliable therapeutic solutions, contributing to the evolving landscape of healthcare technologies.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

26 Patents

#129 in Irvine, CA

#3,039 in California

#12,850 in US

#24,781 in the World

Irvine, CA, United States of America

Sicor Inc.

Forward Citations = 28

35 inventors:

Nicola Diulgheroff (14 out of 14 patents)

Alessandro Pontiroli (14 out of 24 patents)

Judith Aronhime (9 out of 89 patents)

4. Jonathan Busolli (8 out of 8 patents)

5. Marco Villa (8 out of 35 patents)

Please report any incorrect information to [email protected]

Loading…